Skandinaviska Enskilda Banken (SEB)’s Cardiovascular Systems, Inc. CSII Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-35,222
Closed -$506K 1055
2022
Q2
$506K Buy
35,222
+9,353
+36% +$162K ﹤0.01% 809
2022
Q1
$585K Sell
25,869
-12,839
-33% -$249K ﹤0.01% 818
2021
Q4
$754K Sell
38,708
-15,500
-29% -$414K ﹤0.01% 804
2021
Q3
$1.78M Buy
54,208
+17,254
+47% +$644K 0.01% 674
2021
Q2
$1.58M Buy
36,954
+1,067
+3% +$41.7K 0.01% 727
2021
Q1
$1.38M Buy
35,887
+4,799
+15% +$204K 0.01% 759
2020
Q4
$1.36M Buy
31,088
+10,054
+48% +$378K 0.01% 755
2020
Q3
$828K Buy
21,034
+20,559
+4,328% +$664K 0.01% 765
2020
Q2
$15K Buy
+475
New +$17.7K ﹤0.01% 1029

Other funds holding CSII

Skandinaviska Enskilda Banken (SEB)'s CSII Position: Q3 2022 in Review

Skandinaviska Enskilda Banken (SEB) sold out of Cardiovascular Systems, Inc. (CSII) in Q3 2022, closing a stake of 35,222 shares — an estimated $506K sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in CSII in Q2 2020 and held it in 9 quarters. The position peaked at $1.78M in Q3 2021. 163 funds tracked by Wall St. Rank hold CSII as of Q3 2022.

  • Skandinaviska Enskilda Banken (SEB) reported no remaining Cardiovascular Systems, Inc. position as of Q3 2022 after selling out during the quarter.
  • Skandinaviska Enskilda Banken (SEB) sold 35,222 Cardiovascular Systems, Inc. shares in Q3 2022, an estimated $506K.
  • Skandinaviska Enskilda Banken (SEB) first reported a position in Cardiovascular Systems, Inc. in Q2 2020 and held it in 9 quarters.
  • Skandinaviska Enskilda Banken (SEB)'s Cardiovascular Systems, Inc. position peaked at $1.78M in Q3 2021.
  • 163 funds tracked by Wall St. Rank held Cardiovascular Systems, Inc. as of Q3 2022.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q3 2022, filed 14 Nov 2022.